André T - Search Results

1

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.

Goey KKH, Sørbye H, Glimelius B, Adams RA, André T, Arnold D, Berlin JD, Bodoky G, de Gramont A, Díaz-Rubio E, Eng C, Falcone A, Grothey A, Heinemann V, Hochster HS, Kaplan RS, Kopetz S, Labianca R, Lieu CH, Meropol NJ, Price TJ, Schilsky RL, Schmoll HJ, Shacham-Shmueli E, Shi Q, Sobrero AF, Souglakos J, Van Cutsem E, Zalcberg J, van Oijen MGH, Punt CJA, Koopman M. Goey KKH, et al. Among authors: andre t. Eur J Cancer. 2018 Sep;100:35-45. doi: 10.1016/j.ejca.2018.05.010. Epub 2018 Jun 22. Eur J Cancer. 2018. PMID: 29936065

2

[Chemotherapy of colorectal cancers with metastases].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Krulik M. de Gramont A, et al. Among authors: andre t. Presse Med. 1996 Nov 16;25(35):1678-82. Presse Med. 1996. PMID: 8977579 Review. French.

3

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M. Beerblock K, et al. Among authors: andre t. Cancer. 1997 Mar 15;79(6):1100-5. Cancer. 1997. PMID: 9070486 Clinical Trial.

4

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.

de Gramont A, Vignoud J, Tournigand C, Louvet C, André T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1997 Feb;33(2):214-9. doi: 10.1016/s0959-8049(96)00370-x. Eur J Cancer. 1997. PMID: 9135491 Clinical Trial.

5

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Molitor JL, Krulik M. de Gramont A, et al. Among authors: andre t. Rev Med Interne. 1997;18 Suppl 4:372s-378s. doi: 10.1016/s0248-8663(97)83768-x. Rev Med Interne. 1997. PMID: 9365715 Review. French.

6

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

de Gramont A, Louvet C, André T, Tournigand C, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1998 Apr;34(5):619-26. doi: 10.1016/s0959-8049(97)00364-x. Eur J Cancer. 1998. PMID: 9713264 Review.

7

[Adenocarcinoma of the pancreas. General characteristics].

André T, Balosso J, Louvet C, Gligorov J, Callard P, de Gramont A, Izrael V. André T, et al. Presse Med. 1998 Mar 21;27(11):533-6. Presse Med. 1998. PMID: 9767968 Review. French.

8

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

André T, Louvet C, Raymond E, Tournigand C, de Gramont A. André T, et al. Ann Oncol. 1998 Nov;9(11):1251-3. doi: 10.1023/a:1008475122124. Ann Oncol. 1998. PMID: 9862058 Free article. Clinical Trial.

9

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

Maindrault-Goebel F, Louvet C, André T, Carola E, Lotz JP, Molitor JL, Garcia ML, Gilles-Amar V, Izrael V, Krulik M, de Gramont A. Maindrault-Goebel F, et al. Among authors: andre t. Eur J Cancer. 1999 Sep;35(9):1338-42. doi: 10.1016/s0959-8049(99)00149-5. Eur J Cancer. 1999. PMID: 10658524 Clinical Trial.

10

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.

André T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP, Gilles-Amar V, Krulik M, Carola E, Izrael V, de Gramont A. André T, et al. Eur J Cancer. 1999 Sep;35(9):1343-7. doi: 10.1016/s0959-8049(99)00150-1. Eur J Cancer. 1999. PMID: 10658525 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters